Last reviewed · How we verify
EGCG, FA, HA, B12 — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
EGCG, FA, HA, B12 (EGCG, FA, HA, B12) — Centro di Ricerca Clinica Salentino.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| EGCG, FA, HA, B12 TARGET | EGCG, FA, HA, B12 | Centro di Ricerca Clinica Salentino | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- EGCG, FA, HA, B12 CI watch — RSS
- EGCG, FA, HA, B12 CI watch — Atom
- EGCG, FA, HA, B12 CI watch — JSON
- EGCG, FA, HA, B12 alone — RSS
Cite this brief
Drug Landscape (2026). EGCG, FA, HA, B12 — Competitive Intelligence Brief. https://druglandscape.com/ci/egcg-fa-ha-b12. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab